Celldex Therapeutics, Inc. (CLDX)
27.53
-1.40
(-4.84%)
USD |
NASDAQ |
Oct 16, 16:00
27.53
0.00 (0.00%)
After-Hours: 17:44
Celldex Therapeutics Market Cap : 2.161B for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 15, 2026 | 2.271B |
| October 14, 2026 | 2.185B |
| October 13, 2026 | 2.218B |
| October 12, 2026 | 2.310B |
| October 09, 2026 | 2.346B |
| October 08, 2026 | 2.300B |
| October 07, 2026 | 2.389B |
| October 06, 2026 | 2.434B |
| October 05, 2026 | 2.558B |
| October 02, 2026 | 2.485B |
| October 01, 2026 | 2.526B |
| September 30, 2026 | 2.544B |
| September 29, 2026 | 2.484B |
| September 28, 2026 | 2.472B |
| September 25, 2026 | 2.441B |
| September 24, 2026 | 2.471B |
| September 23, 2026 | 2.443B |
| September 22, 2026 | 2.631B |
| September 21, 2026 | 2.974B |
| September 18, 2026 | 3.002B |
| September 17, 2026 | 3.060B |
| September 16, 2026 | 3.039B |
| September 15, 2026 | 3.023B |
| September 14, 2026 | 3.076B |
| September 11, 2026 | 2.897B |
| Date | Value |
|---|---|
| September 10, 2026 | 2.991B |
| September 09, 2026 | 3.044B |
| September 08, 2026 | 3.071B |
| September 04, 2026 | 3.115B |
| September 03, 2026 | 3.091B |
| September 02, 2026 | 3.099B |
| September 01, 2026 | 3.080B |
| August 31, 2026 | 3.111B |
| August 28, 2026 | 3.071B |
| August 27, 2026 | 3.176B |
| August 26, 2026 | 3.185B |
| August 25, 2026 | 3.236B |
| August 24, 2026 | 3.185B |
| August 21, 2026 | 3.170B |
| August 20, 2026 | 3.135B |
| August 19, 2026 | 3.273B |
| August 18, 2026 | 3.281B |
| August 17, 2026 | 3.291B |
| August 14, 2026 | 3.293B |
| August 13, 2026 | 3.345B |
| August 12, 2026 | 3.522B |
| August 11, 2026 | 3.480B |
| August 10, 2026 | 3.373B |
| August 07, 2026 | 3.274B |
| August 06, 2026 | 3.262B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 193.83B |
| ACADIA Pharmaceuticals, Inc. | 3.293B |
| Alnylam Pharmaceuticals, Inc. | 31.01B |
| Anika Therapeutics, Inc. | 267.79M |
| Savara, Inc. | 914.03M |
Market Cap Related Metrics
| PS Ratio | 12079.88 |
| PEG Ratio | -0.1406 |
| Price to Book Value | 3.024 |
| Price | 27.53 |
| Earnings Yield | -15.83% |
| PEGY Ratio | -0.1406 |